Pages that link to "Q33634797"

The following pages link to Trans-activating rev protein of the human immunodeficiency virus 1 interacts directly and specifically with its target RNA. (Q33634797):

Displaying 34 items.

• Heterocyclic compounds that inhibit Rev-RRE function and human immunodeficiency virus type 1 replication (Q24652351) (← links)
• The basic domain of Rev from human immunodeficiency virus type 1 specifically blocks the entry of U4/U6.U5 small nuclear ribonucleoprotein in spliceosome assembly (Q24656044) (← links)
• Eukaryotic initiation factor 5A is a cellular target of the human immunodeficiency virus type 1 Rev activation domain mediating trans-activation (Q24657633) (← links)
• A chimeric human immunodeficiency virus type 1 (HIV-1) minimal Rev response element-ribozyme molecule exhibits dual antiviral function and inhibits cell-cell transmission of HIV-1 (Q24683706) (← links)
• Inhibition of human immunodeficiency virus type 1 Rev-Rev-response element complex formation by complementary oligonucleotides (Q28324342) (← links)
• A long-awaited structure is rev-ealed (Q30407389) (← links)
• Single-Nucleotide Changes in the HIV Rev-Response Element Mediate Resistance to Compounds That Inhibit Rev Function (Q30430496) (← links)
• Specific binding of a basic peptide from HIV-1 Rev (Q33937528) (← links)
• Formation of trans-activation competent HIV-1 Rev:RRE complexes requires the recruitment of multiple protein activation domains (Q34295820) (← links)
• Oligomerization and RNA binding domains of the type 1 human immunodeficiency virus Rev protein: a dual function for an arginine-rich binding motif (Q34588875) (← links)
• A Rev-inducible mutant gag gene stably transferred into T lymphocytes: an approach to gene therapy against human immunodeficiency virus type 1 infection (Q35189274) (← links)
• Mechanism of action of regulatory proteins encoded by complex retroviruses (Q35403061) (← links)
• Characterization of HIV-1 REV protein: binding stoichiometry and minimal RNA substrate (Q35919477) (← links)
• Equine infectious anemia virus trans-regulatory protein Rev controls viral mRNA stability, accumulation, and alternative splicing (Q36633475) (← links)
• Inhibition of Rev activity and human immunodeficiency virus type 1 replication by antisense oligodeoxynucleotide phosphorothioate analogs directed against the Rev-responsive element (Q36654713) (← links)
• Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein (Q36655924) (← links)
• Human immunodeficiency virus type 1 Rev activation can be achieved without Rev-responsive element RNA if Rev is directed to the target as a Rev/MS2 fusion protein which tethers the MS2 operator RNA (Q36687462) (← links)
• A specific sequence with a bulged guanosine residue(s) in a stem-bulge-stem structure of Rev-responsive element RNA is required for trans activation by human immunodeficiency virus type 1 Rev (Q36698182) (← links)
• Comparative analysis of Rev function in human immunodeficiency virus types 1 and 2. (Q36698908) (← links)
• The Rev protein of human immunodeficiency virus type 1 promotes polysomal association and translation of gag/pol and vpu/env mRNAs (Q36964078) (← links)
• Genetic regulation of human immunodeficiency virus. (Q37056955) (← links)
• Specific inhibition of human immunodeficiency virus type 1 replication by antisense oligonucleotides: an in vitro model for treatment (Q37313430) (← links)
• Structural analysis of the interaction between the human immunodeficiency virus Rev protein and the Rev response element (Q37381376) (← links)
• Attenuating HIV Tat/TAR-mediated protein expression by exploring the side chain length of positively charged residues. (Q38833059) (← links)
• Dominant-negative mutants are clustered in a domain of the human T-cell leukemia virus type I Rex protein: implications for trans dominance (Q40066482) (← links)
• Functional mapping of the human immunodeficiency virus type 1 Rev RNA binding domain: new insights into the domain structure of Rev and Rex. (Q40116014) (← links)
• In vivo binding of wild-type and mutant human immunodeficiency virus type 1 Rev proteins: implications for function (Q40309262) (← links)
• Regulation of human immunodeficiency virus infection: implications for pathogenesis (Q40756505) (← links)
• Intracellular structure and nucleocytoplasmic transport. (Q40943120) (← links)
• Gene-targeted inhibition of transactivation of human immunodeficiency virus type-1 (HIV-1)-LTR by antisense oligonucleotides (Q41395911) (← links)
• Mechanisms involved in natural and experimental neuropathogenicity of influenza viruses: evidence and speculation. (Q41729122) (← links)
• Inhibition of HIV Production in Cells Containing an Integrated, HIV-Regulated Diphtheria Toxin A Chain Gene (Q42468168) (← links)
• Host virus interactions and the molecular regulation of HIV-1: role in the pathogenesis of HIV-associated nephropathy (Q45782813) (← links)
• Intermolecular binding sites of human immunodeficiency virus type 1 Rev protein determined by protein footprinting. (Q45789207) (← links)